SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5cfv'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C4D_B_DVAB8_0 (GRAMICIDIN A)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Escherichia coli; Acinetobacter nosocomialis)	3 / 3	TRP A 158 VAL A 259 TRP A 340	None None MAL A1201 (-3.7A)	1.25A	1c4dA-5cfvA: undetectable 1c4dB-5cfvA: undetectable	1c4dA-5cfvA: 5.21 1c4dB-5cfvA: 5.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E06_A_IPBA600_0 (ODORANT-BINDING PROTEIN)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Escherichia coli; Acinetobacter nosocomialis)	4 / 6	VAL A 8 VAL A 50 ILE A 60 ASN A 267	None	0.96A	1e06A-5cfvA: undetectable	1e06A-5cfvA: 15.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E7A_B_PFLB4001_1 (SERUM ALBUMIN)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	5 / 9	ILE A 9 LEU A 262 VAL A 293 GLY A 16 LEU A 284	None	1.25A	1e7aB-5cfvA: undetectable	1e7aB-5cfvA: 22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QU2_A_MRCA1993_2 (ISOLEUCYL-TRNA SYNTHETASE)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	3 / 3	GLU A 111 TRP A 230 LYS A 273	MAL A1201 (-3.0A) MAL A1201 ( 4.5A) None	1.24A	1qu2A-5cfvA: undetectable	1qu2A-5cfvA: 20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q6O_A_SAMA500_0 (HYPOTHETICAL PROTEIN)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Escherichia coli; Acinetobacter nosocomialis)	4 / 7	VAL A 97 ALA A 105 PHE A 92 PRO A 91	None	1.07A	2q6oA-5cfvA: undetectable	2q6oA-5cfvA: 21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VE3_A_REAA1445_1 (PUTATIVE CYTOCHROME P450 120)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	5 / 12	ALA A 264 LEU A 280 PHE A 279 VAL A 293 GLY A 16	None	1.11A	2ve3A-5cfvA: undetectable	2ve3A-5cfvA: 21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BGD_A_PM6A301_1 (THIOPURINE S-METHYLTRANSFERASE)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	4 / 6	PHE A 258 ALA A 162 LEU A 247 PRO A 159	None	0.95A	3bgdA-5cfvA: undetectable	3bgdA-5cfvA: 18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_C_SVRC507_1 (PHOSPHOLIPASE A2)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	4 / 7	VAL A 110 GLY A 300 PRO A 229 LYS A 305	None	0.72A	3bjwC-5cfvA: undetectable	3bjwC-5cfvA: 13.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_G_SVRG506_1 (PHOSPHOLIPASE A2)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	4 / 8	VAL A 110 GLY A 300 PRO A 229 LYS A 305	None	0.89A	3bjwA-5cfvA: undetectable	3bjwA-5cfvA: 13.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GV1_A_BEZA302_0 (DISULFIDE INTERCHANGE PROTEIN)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Escherichia coli; Acinetobacter nosocomialis)	4 / 6	PRO A 126 LEU A 147 ALA A 223 PRO A 125	None	1.31A	3gv1A-5cfvA: undetectable 3gv1C-5cfvA: undetectable	3gv1A-5cfvA: 15.96 3gv1C-5cfvA: 15.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GV1_B_BEZB301_0 (DISULFIDE INTERCHANGE PROTEIN)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Escherichia coli; Acinetobacter nosocomialis)	4 / 6	LEU A 147 ALA A 223 PRO A 125 PRO A 126	None	1.29A	3gv1A-5cfvA: undetectable 3gv1B-5cfvA: undetectable	3gv1A-5cfvA: 15.96 3gv1B-5cfvA: 15.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HS6_A_EPAA1_1 (PROSTAGLANDIN G/H SYNTHASE 2)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	5 / 12	VAL A 343 GLY A 187 ALA A 188 LEU A 192 LEU A 160	None	1.05A	3hs6A-5cfvA: undetectable	3hs6A-5cfvA: 20.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_1 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	9 / 12	ASP A 14 LYS A 15 LYS A 42 GLU A 44 GLU A 45 ALA A 63 ASP A 65 ARG A 66 GLU A 111	MAL A1201 (-3.0A) MAL A1201 (-2.8A) None None None MAL A1201 (-3.3A) MAL A1201 (-2.8A) MAL A1201 (-3.8A) MAL A1201 (-3.0A)	0.79A	3jyrA-5cfvA: 55.2	3jyrA-5cfvA: 72.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_1 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	10 / 12	ASP A 14 LYS A 15 LYS A 42 GLU A 44 GLU A 45 ALA A 63 ASP A 65 GLU A 111 PRO A 154 TRP A 230	MAL A1201 (-3.0A) MAL A1201 (-2.8A) None None None MAL A1201 (-3.3A) MAL A1201 (-2.8A) MAL A1201 (-3.0A) MAL A1201 (-3.4A) MAL A1201 ( 4.5A)	0.50A	3jyrA-5cfvA: 55.2	3jyrA-5cfvA: 72.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_2 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	7 / 7	ASN A 12 TRP A 62 GLU A 153 TYR A 155 MET A 330 TRP A 340 ARG A 344	MAL A1201 (-4.5A) MAL A1201 (-4.4A) MAL A1201 (-3.6A) MAL A1201 (-3.9A) MAL A1201 (-4.3A) MAL A1201 (-3.7A) None	0.79A	3jyrA-5cfvA: 55.2	3jyrA-5cfvA: 72.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SG9_B_KANB305_1 (APH(2'')-ID)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	4 / 8	ASN A 185 ASP A 180 GLU A 328 TRP A 158	None None GOL A1205 (-2.5A) None	0.96A	3sg9B-5cfvA: undetectable	3sg9B-5cfvA: 22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SJ4_X_DXCX75_0 (CYTOCHROME C7)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Escherichia coli; Acinetobacter nosocomialis)	5 / 9	ILE A 132 LEU A 198 LYS A 256 ILE A 226 GLY A 191	None	1.25A	3sj4X-5cfvA: undetectable	3sj4X-5cfvA: 8.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	5 / 12	PHE A 156 GLY A 300 LEU A 299 GLU A 111 ALA A 231	None None None MAL A1201 (-3.0A) None	0.85A	3tbgB-5cfvA: undetectable	3tbgB-5cfvA: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	5 / 12	PHE A 156 GLY A 300 LEU A 299 GLU A 111 ALA A 231	None None None MAL A1201 (-3.0A) None	0.83A	3tbgD-5cfvA: undetectable	3tbgD-5cfvA: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VWQ_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	5 / 12	ALA A 231 TYR A 17 TYR A 210 ASN A 234 GLY A 228	None	1.36A	3vwqA-5cfvA: undetectable	3vwqA-5cfvA: 21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VYW_D_SAMD401_1 (MNMC2)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Escherichia coli; Acinetobacter nosocomialis)	4 / 5	GLU A 308 ASP A 314 ASP A 287 ASN A 294	None	1.36A	3vywD-5cfvA: undetectable	3vywD-5cfvA: 21.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IKI_A_IMNA201_1 (TRANSTHYRETIN)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	3 / 3	LYS A 142 LEU A 139 ALA A 141	None	0.67A	4ikiA-5cfvA: undetectable	4ikiA-5cfvA: 14.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N48_A_SAMA601_1 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Escherichia coli; Acinetobacter nosocomialis)	4 / 5	ASN A 267 ALA A 51 GLY A 56 ASP A 14	None None None MAL A1201 (-3.0A)	0.97A	4n48A-5cfvA: undetectable	4n48A-5cfvA: 22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OR0_B_NPSB602_1 (SERUM ALBUMIN)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	5 / 9	ALA A 264 ALA A 105 LEU A 103 LEU A 262 VAL A 261	None	1.16A	4or0B-5cfvA: undetectable	4or0B-5cfvA: 22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KVA_A_SAMA301_0 (CAFFEOYL-COA O-METHYLTRANSFERASE)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Escherichia coli; Acinetobacter nosocomialis)	5 / 12	GLY A1042 ILE A1079 ALA A1077 ASP A1041 ALA A1040	None	1.21A	5kvaA-5cfvA: undetectable	5kvaA-5cfvA: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XIW_D_LOCD503_2 (TUBULIN BETA CHAIN)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Acinetobacter nosocomialis; Escherichia coli)	5 / 12	LEU A 139 LEU A 122 ASN A 124 ILE A 132 LYS A 127	None	1.29A	5xiwD-5cfvA: undetectable	5xiwD-5cfvA: 10.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B58_A_ACTA603_0 (FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Escherichia coli; Acinetobacter nosocomialis)	3 / 3	TYR A 155 ASN A 227 LEU A 113	MAL A1201 (-3.9A) None None	0.81A	6b58A-5cfvA: undetectable	6b58A-5cfvA: 22.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BM5_A_SAMA1301_0 (METHIONINE SYNTHASE)	5cfv	MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BIND ING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN (Escherichia coli; Acinetobacter nosocomialis)	5 / 11	PRO A 133 GLU A 130 PRO A 254 ALA A 163 PRO A 159	None	1.43A	6bm5A-5cfvA: undetectable	6bm5A-5cfvA: 22.20

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1C4D_B_DVAB8_0","GRAMICIDIN A","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Escherichia coli;Acinetobacter nosocomialis",3,"TRP A 158;VAL A 259;TRP A 340","None;None;MAL A1201 (-3.7A)","1.25A","1c4dA-5cfvA:undetectable;1c4dB-5cfvA:undetectable","1c4dA-5cfvA:5.21;1c4dB-5cfvA:5.21"],["1E06_A_IPBA600_0","ODORANT-BINDING PROTEIN","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Escherichia coli;Acinetobacter nosocomialis",4,"VAL A   8;VAL A  50;ILE A  60;ASN A 267","None","0.96A","1e06A-5cfvA:undetectable","1e06A-5cfvA:15.15"],["1E7A_B_PFLB4001_1","SERUM ALBUMIN","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",5,"ILE A   9;LEU A 262;VAL A 293;GLY A  16;LEU A 284","None","1.25A","1e7aB-5cfvA:undetectable","1e7aB-5cfvA:22.66"],["1QU2_A_MRCA1993_2","ISOLEUCYL-TRNA SYNTHETASE","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",3,"GLU A 111;TRP A 230;LYS A 273","MAL A1201 (-3.0A);MAL A1201 ( 4.5A);None","1.24A","1qu2A-5cfvA:undetectable","1qu2A-5cfvA:20.43"],["2Q6O_A_SAMA500_0","HYPOTHETICAL PROTEIN","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Escherichia coli;Acinetobacter nosocomialis",4,"VAL A  97;ALA A 105;PHE A  92;PRO A  91","None","1.07A","2q6oA-5cfvA:undetectable","2q6oA-5cfvA:21.76"],["2VE3_A_REAA1445_1","PUTATIVE CYTOCHROME P450 120","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",5,"ALA A 264;LEU A 280;PHE A 279;VAL A 293;GLY A  16","None","1.11A","2ve3A-5cfvA:undetectable","2ve3A-5cfvA:21.51"],["3BGD_A_PM6A301_1","THIOPURINE S-METHYLTRANSFERASE","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",4,"PHE A 258;ALA A 162;LEU A 247;PRO A 159","None","0.95A","3bgdA-5cfvA:undetectable","3bgdA-5cfvA:18.75"],["3BJW_C_SVRC507_1","PHOSPHOLIPASE A2","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",4,"VAL A 110;GLY A 300;PRO A 229;LYS A 305","None","0.72A","3bjwC-5cfvA:undetectable","3bjwC-5cfvA:13.41"],["3BJW_G_SVRG506_1","PHOSPHOLIPASE A2;PHOSPHOLIPASE A2","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",4,"VAL A 110;GLY A 300;PRO A 229;LYS A 305","None","0.89A","3bjwA-5cfvA:undetectable","3bjwA-5cfvA:13.41"],["3GV1_A_BEZA302_0","DISULFIDE INTERCHANGE PROTEIN","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Escherichia coli;Acinetobacter nosocomialis",4,"PRO A 126;LEU A 147;ALA A 223;PRO A 125","None","1.31A","3gv1A-5cfvA:undetectable;3gv1C-5cfvA:undetectable","3gv1A-5cfvA:15.96;3gv1C-5cfvA:15.96"],["3GV1_B_BEZB301_0","DISULFIDE INTERCHANGE PROTEIN","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Escherichia coli;Acinetobacter nosocomialis",4,"LEU A 147;ALA A 223;PRO A 125;PRO A 126","None","1.29A","3gv1A-5cfvA:undetectable;3gv1B-5cfvA:undetectable","3gv1A-5cfvA:15.96;3gv1B-5cfvA:15.96"],["3HS6_A_EPAA1_1","PROSTAGLANDIN G\/H SYNTHASE 2","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",5,"VAL A 343;GLY A 187;ALA A 188;LEU A 192;LEU A 160","None","1.05A","3hs6A-5cfvA:undetectable","3hs6A-5cfvA:20.89"],["3JYR_A_ACRA371_1","MALTOSE-BINDING PERIPLASMIC PROTEIN","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",9,"ASP A  14;LYS A  15;LYS A  42;GLU A  44;GLU A  45;ALA A  63;ASP A  65;ARG A  66;GLU A 111","MAL A1201 (-3.0A);MAL A1201 (-2.8A);None;None;None;MAL A1201 (-3.3A);MAL A1201 (-2.8A);MAL A1201 (-3.8A);MAL A1201 (-3.0A)","0.79A","3jyrA-5cfvA:55.2","3jyrA-5cfvA:72.65"],["3JYR_A_ACRA371_1","MALTOSE-BINDING PERIPLASMIC PROTEIN","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",10,"ASP A  14;LYS A  15;LYS A  42;GLU A  44;GLU A  45;ALA A  63;ASP A  65;GLU A 111;PRO A 154;TRP A 230","MAL A1201 (-3.0A);MAL A1201 (-2.8A);None;None;None;MAL A1201 (-3.3A);MAL A1201 (-2.8A);MAL A1201 (-3.0A);MAL A1201 (-3.4A);MAL A1201 ( 4.5A)","0.50A","3jyrA-5cfvA:55.2","3jyrA-5cfvA:72.65"],["3JYR_A_ACRA371_2","MALTOSE-BINDING PERIPLASMIC PROTEIN","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",7,"ASN A  12;TRP A  62;GLU A 153;TYR A 155;MET A 330;TRP A 340;ARG A 344","MAL A1201 (-4.5A);MAL A1201 (-4.4A);MAL A1201 (-3.6A);MAL A1201 (-3.9A);MAL A1201 (-4.3A);MAL A1201 (-3.7A);None","0.79A","3jyrA-5cfvA:55.2","3jyrA-5cfvA:72.65"],["3SG9_B_KANB305_1","APH(2'')-ID","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",4,"ASN A 185;ASP A 180;GLU A 328;TRP A 158","None;None;GOL A1205 (-2.5A);None","0.96A","3sg9B-5cfvA:undetectable","3sg9B-5cfvA:22.09"],["3SJ4_X_DXCX75_0","CYTOCHROME C7","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Escherichia coli;Acinetobacter nosocomialis",5,"ILE A 132;LEU A 198;LYS A 256;ILE A 226;GLY A 191","None","1.25A","3sj4X-5cfvA:undetectable","3sj4X-5cfvA:8.48"],["3TBG_B_RTZB1_1","CYTOCHROME P450 2D6","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",5,"PHE A 156;GLY A 300;LEU A 299;GLU A 111;ALA A 231","None;None;None;MAL A1201 (-3.0A);None","0.85A","3tbgB-5cfvA:undetectable","3tbgB-5cfvA:21.18"],["3TBG_D_RTZD1_1","CYTOCHROME P450 2D6","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",5,"PHE A 156;GLY A 300;LEU A 299;GLU A 111;ALA A 231","None;None;None;MAL A1201 (-3.0A);None","0.83A","3tbgD-5cfvA:undetectable","3tbgD-5cfvA:21.18"],["3VWQ_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",5,"ALA A 231;TYR A  17;TYR A 210;ASN A 234;GLY A 228","None","1.36A","3vwqA-5cfvA:undetectable","3vwqA-5cfvA:21.61"],["3VYW_D_SAMD401_1","MNMC2","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Escherichia coli;Acinetobacter nosocomialis",4,"GLU A 308;ASP A 314;ASP A 287;ASN A 294","None","1.36A","3vywD-5cfvA:undetectable","3vywD-5cfvA:21.02"],["4IKI_A_IMNA201_1","TRANSTHYRETIN","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",3,"LYS A 142;LEU A 139;ALA A 141","None","0.67A","4ikiA-5cfvA:undetectable","4ikiA-5cfvA:14.47"],["4N48_A_SAMA601_1","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Escherichia coli;Acinetobacter nosocomialis",4,"ASN A 267;ALA A  51;GLY A  56;ASP A  14","None;None;None;MAL A1201 (-3.0A)","0.97A","4n48A-5cfvA:undetectable","4n48A-5cfvA:22.07"],["4OR0_B_NPSB602_1","SERUM ALBUMIN","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",5,"ALA A 264;ALA A 105;LEU A 103;LEU A 262;VAL A 261","None","1.16A","4or0B-5cfvA:undetectable","4or0B-5cfvA:22.36"],["5KVA_A_SAMA301_0","CAFFEOYL-COA O-METHYLTRANSFERASE","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Escherichia coli;Acinetobacter nosocomialis",5,"GLY A1042;ILE A1079;ALA A1077;ASP A1041;ALA A1040","None","1.21A","5kvaA-5cfvA:undetectable","5kvaA-5cfvA:19.76"],["5XIW_D_LOCD503_2","TUBULIN BETA CHAIN","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Acinetobacter nosocomialis;Escherichia coli",5,"LEU A 139;LEU A 122;ASN A 124;ILE A 132;LYS A 127","None","1.29A","5xiwD-5cfvA:undetectable","5xiwD-5cfvA:10.27"],["6B58_A_ACTA603_0","FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Escherichia coli;Acinetobacter nosocomialis",3,"TYR A 155;ASN A 227;LEU A 113","MAL A1201 (-3.9A);None;None","0.81A","6b58A-5cfvA:undetectable","6b58A-5cfvA:22.28"],["6BM5_A_SAMA1301_0","METHIONINE SYNTHASE","5cfv","MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING PERIPLASMIC PROTEIN,PILA FUSION PROTEIN","Escherichia coli;Acinetobacter nosocomialis",5,"PRO A 133;GLU A 130;PRO A 254;ALA A 163;PRO A 159","None","1.43A","6bm5A-5cfvA:undetectable","6bm5A-5cfvA:22.20"]]